Global and United States Protein in Infant Formula Market Report & Forecast 2023-2029
- Report Code : ARS2755103
- Published On: Jan, 2024
- Category : Food & Beverages
- Pages : 112
-
The research time span covered by the report is from 2018 to 2029; it provides an overview of the Global Protein in Infant Formula Market and also provides a deeper in-depth segmentation of the market by regions, product type and downstream industries.
The global Protein in Infant Formula market size in 2022 is 6425.6 million US dollars, and it is expected to be 11012.3 million US dollars by 2029, with a compound annual growth rate of 8.00% expected in 2023-2029.
MARKET COMPETITIVE LANDSCAPE:
The main players in the Protein in Infant Formula market include ZuChem Inc. (U.S.), Elicityl SA (France), Jennewein Biotechnologie GmbH (Germany), Royal FrieslandCampina NV (Netherlands), and BASF SE (Germany). The share of the top 3 players in the Protein in Infant Formula market is XX%.
REGION SHARE:
The report covers the market size information of North America, Europe, Asia Pacific, Latin America, Middle East and Africa, and North America accounted for XX%, Europe accounted for XX% of Protein in Infant Formula market, and Asia Pacific accounted for XX%.
SEGMENT OVERVIEW:
The report segments the market by Type and Application. Growing-up Milk accounted for XX% of Protein in Infant Formula market in 2022. Standard Infant Formula share of XX%.
Hypermarkets accounted for XX% of the Protein in Infant Formula market in 2022. Supermarkets accounts for XX%.
For competitive landscape, prominent players with considerable market shares are comprehensively analyzed in this report. With information regarding the concentration ratio and detailed data reflecting the market performance of each player shared, the readers can acquire a holistic view of the competitive situation and a better understanding of their competitors.
As the COVID-19 takes over the world, we are continuously tracking the changes in the markets. We analyzed the impact of the pandemic in detail, along with other key factors, such as macro-economy, regional conflicts, industry related news and policies. Meanwhile, market investment scenario, technology status and developments, supply chain challenges, among other essential research elements are all covered.
Key Factors Considered:
COVID-19
The report describes the market scenario during and post the pandemic in the vision of upstream, major market participants, downstream major customers, etc. Other aspects, such as changes in consumer behavior, demand, transport capacity, trade flow under COVID-19, have also been taken into consideration during the process of the research.
Regional Conflict / Russia-Ukraine War
The report also presents the impact of regional conflict on this market in an effort to aid the readers to understand how the market has been adversely influenced and how it's going to evolve in the years to come.
Challenges & Opportunities
Factors that may help create opportunities and boost profits for market players, as well as challenges that may restrain or even pose a threat to the development of the players, are revealed in the report, which can shed a light on strategic decisions and implementation.
Chapter Outline
Chapter 1: Introduces the product overview, market scope, study objectives, and industry dynamic analysis, and then includes the global impact of the coronavirus disease (COVID-19).
Chapter 2: Analysis of the competitive environment of Protein in Infant Formula market participants. This mainly includes the revenue, sales, market share, and average price of the top players, along with the players' M&A and expansion in recent years.
Chapters 3-6: Segmented the global Protein in Infant Formula market by type, application and region. Analyze the revenue of market segments from different perspectives.
Chapter 7: Analyzes the main companies in the Protein in Infant Formula industry, including their main businesses, products/services, sales, revenue, gross margin, and the latest developments.
Chapter 8: Analyzes the Protein in Infant Formula industry chain, including raw material analysis, sales and marketing, distributors and major downstream buyers.
Chapter 9: The main points and conclusions of the report.
Chapter 10: Concludes with an explanation of the data sources and research methods.
Highlights-Regions
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Asia Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Latin America
Brazil
Argentina
Mexico
MEA
Saudi Arabia
UAE
Turkey
Player list
ZuChem Inc. (U.S.)
Elicityl SA (France)
Jennewein Biotechnologie GmbH (Germany)
Royal FrieslandCampina NV (Netherlands)
BASF SE (Germany)
Gnubiotics (Switzerland)
DuPont Nutrition & Health (Denmark)
Inbiose NV (Belgium)
Glycom A/S (Denmark)
Glycosyn LLC (U.S.)
Types list
Growing-up Milk
Standard Infant Formula
Follow-on Formula
Specialty
Application list
Hypermarkets
Supermarkets
Pharmacy/Medical Store
Specialty Stores
Hard Discounter Stores
Others
-
With tables and figures helping analyze worldwide Global and United States Protein in Infant Formula market, this research provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.
Table of Content
1 Study Coverage1.1 Protein in Infant Formula Product Introduction
1.2 Global Protein in Infant Formula Outlook 2018 VS 2023 VS 2029
1.3 United States Protein in Infant Formula Outlook 2018 VS 2023 VS 2029
1.4 Protein in Infant Formula Market Size, United States VS Global, 2018-2029
1.4.1 The Market Share of United States Protein in Infant Formula in Global, 2018-2029
1.4.2 The Growth Rate of Protein in Infant Formula Market Size, United States VS Global, 2018 VS 2023 VS 20291.5 Protein in Infant Formula Market Dynamics
1.5.1 Protein in Infant Formula Market Trends
1.5.2 Protein in Infant Formula Market Drivers
1.5.3 Protein in Infant Formula Market Challenges
1.5.4 Protein in Infant Formula Market Restraints1.6 Study Objectives
1.7 Years Considered
1.8 Coronavirus Disease (COVID-19) Impact on Global
2 Global Protein in Infant Formula Competitor Landscape by Company2.1 Global Protein in Infant Formula Market Size by Company
2.1.1 Top Global Protein in Infant Formula Player Ranked by Revenue (2023)
2.1.2 Global Protein in Infant Formula Revenue by Player (2018-2023)2.2 Global Protein in Infant Formula Concentration Ratio (CR)
2.2.1 Protein in Infant Formula Market Concentration Ratio (CR) (2018-2023)
2.2.2 Global Top 3 and Top 6 Largest Players of Protein in Infant Formula in 20232.3 Global Protein in Infant Formula Business Distribution, Business Type
2.3.1 Global Protein in Infant Formula Players, Headquarters and Distribution
2.3.2 Players Protein in Infant Formula Business Type
2.3.3 Date of International Players Enter into Protein in Infant Formula Market2.4 Players Mergers & Acquisitions, Expansion Plans
2.5 United States Protein in Infant Formula Market Size by Company
2.5.1 Top United States Protein in Infant Formula Player s Ranked by Revenue (2023)
2.5.2 United States Protein in Infant Formula Revenue by Player (2018-2023)
3 Protein in Infant Formula Market Segment by Type3.1 Protein in Infant Formula Market Segment by Type
3.2 Global Protein in Infant Formula Market Size by Type
3.3 United States Protein in Infant Formula Market Size by Type
4 Protein in Infant Formula Market Segment by Application4.1 Protein in Infant Formula Market Segment by Application
4.2 Global Protein in Infant Formula Market Size by Application
4.3 United States Protein in Infant Formula Market Size by Application
5 Global Protein in Infant Formula Market Size by Region5.1 Global Protein in Infant Formula Market Size by Region: 2018 VS 2023 VS 2029
5.2 Global Protein in Infant Formula Market Size in Value by Region (2018-2029)
5.2.1 Global Protein in Infant Formula Revenue by Region: 2018-2023
5.2.2 Global Protein in Infant Formula Revenue by Region: 2023-20295.3 Global Protein in Infant Formula Market Size in Volume by Region (2018-2029)
5.3.1 Global Protein in Infant Formula Volume by Region: 2018-2023
5.3.2 Global Protein in Infant Formula Volume by Region: 2023-2029
6 Segment in Regional Level & Country Level6.1 North America
6.1.1 North America Protein in Infant Formula Market Size YoY Growth 2018-2029
6.1.2 North America Protein in Infant Formula Market Facts & Figures by Country (2018-2029)
6.1.3 U.S.
6.1.4 Canada6.2 Asia Pacific
6.2.1 Asia Pacific Protein in Infant Formula Market Size YoY Growth 2018-2029
6.2.2 Asia Pacific Protein in Infant Formula Market Facts & Figures by Country (2018-2029)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Southeast Asia6.3 Europe
6.3.1 Europe Protein in Infant Formula Market Size YoY Growth 2018-2029
6.3.2 Europe Protein in Infant Formula Market Facts & Figures by Country (2018-2029)
6.3.3 Germany
6.3.4 France
6.3.5 UK
6.3.6 Italy
6.3.7 Russia6.4 Latin America
6.4.1 Latin America Protein in Infant Formula Market Size YoY Growth 2018-2029
6.4.2 Latin America Protein in Infant Formula Market Facts & Figures by Country (2018-2029)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina6.5 Middle East and Africa
6.5.1 Middle East and Africa Protein in Infant Formula Market Size YoY Growth 2018-2029
6.5.2 Middle East and Africa Protein in Infant Formula Market Facts & Figures by Country (2018-2029)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 UAE
7 Company Profiles7.1 ZuChem Inc. (U.S.)
7.1.1 ZuChem Inc. (U.S.) Company Details
7.1.2 Description and Business Overview
7.1.3 Protein in Infant Formula Introduction
7.1.4 ZuChem Inc. (U.S.) Protein in Infant Formula Revenue, Sales, and Gross Margin (2018-2023)
7.1.5 ZuChem Inc. (U.S.) Recent Development7.2 Elicityl SA (France)
7.2.1 Elicityl SA (France) Company Details
7.2.2 Description and Business Overview
7.2.3 Protein in Infant Formula Introduction
7.2.4 Elicityl SA (France) Protein in Infant Formula Revenue, Sales, and Gross Margin (2018-2023)
7.2.5 Elicityl SA (France) Recent Development7.3 Jennewein Biotechnologie GmbH (Germany)
7.3.1 Jennewein Biotechnologie GmbH (Germany) Company Details
7.3.2 Description and Business Overview
7.3.3 Protein in Infant Formula Introduction
7.3.4 Jennewein Biotechnologie GmbH (Germany) Protein in Infant Formula Revenue, Sales, and Gross Margin (2018-2023)
7.3.5 Jennewein Biotechnologie GmbH (Germany) Recent Development7.4 Royal FrieslandCampina NV (Netherlands)
7.4.1 Royal FrieslandCampina NV (Netherlands) Company Details
7.4.2 Description and Business Overview
7.4.3 Protein in Infant Formula Introduction
7.4.4 Royal FrieslandCampina NV (Netherlands) Protein in Infant Formula Revenue, Sales, and Gross Margin (2018-2023)
7.4.5 Royal FrieslandCampina NV (Netherlands) Recent Development7.5 BASF SE (Germany)
7.5.1 BASF SE (Germany) Company Details
7.5.2 Description and Business Overview
7.5.3 Protein in Infant Formula Introduction
7.5.4 BASF SE (Germany) Protein in Infant Formula Revenue, Sales, and Gross Margin (2018-2023)
7.5.5 BASF SE (Germany) Recent Development7.6 Gnubiotics (Switzerland)
7.6.1 Gnubiotics (Switzerland) Company Details
7.6.2 Description and Business Overview
7.6.3 Protein in Infant Formula Introduction
7.6.4 Gnubiotics (Switzerland) Protein in Infant Formula Revenue, Sales, and Gross Margin (2018-2023)
7.6.5 Gnubiotics (Switzerland) Recent Development
7.7 DuPont Nutrition & Health (Denmark)
7.7.1 DuPont Nutrition & Health (Denmark) Company Details
7.7.2 Description and Business Overview
7.7.3 Protein in Infant Formula Introduction
7.7.4 DuPont Nutrition & Health (Denmark) Protein in Infant Formula Revenue, Sales, and Gross Margin (2018-2023)
7.7.5 DuPont Nutrition & Health (Denmark) Recent Development
7.8 Inbiose NV (Belgium)
7.8.1 Inbiose NV (Belgium) Company Details
7.8.2 Description and Business Overview
7.8.3 Protein in Infant Formula Introduction
7.8.4 Inbiose NV (Belgium) Protein in Infant Formula Revenue, Sales, and Gross Margin (2018-2023)
7.8.5 Inbiose NV (Belgium) Recent Development
7.9 Glycom A/S (Denmark)
7.9.1 Glycom A/S (Denmark) Company Details
7.9.2 Description and Business Overview
7.9.3 Protein in Infant Formula Introduction
7.9.4 Glycom A/S (Denmark) Protein in Infant Formula Revenue, Sales, and Gross Margin (2018-2023)
7.9.5 Glycom A/S (Denmark) Recent Development7.10 Glycosyn LLC (U.S.)
7.10.1 Glycosyn LLC (U.S.) Company Details
7.10.2 Description and Business Overview
7.10.3 Protein in Infant Formula Introduction
7.10.4 Glycosyn LLC (U.S.) Protein in Infant Formula Revenue, Sales, and Gross Margin (2018-2023)
7.10.5 Glycosyn LLC (U.S.) Recent Development
8 Industry Chain and Sales Channels Analysis8.1 Protein in Infant Formula Value Chain Analysis
8.2 Protein in Infant Formula Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Distributors List8.3 Protein in Infant Formula Production Mode & Process
8.4 Protein in Infant Formula Sales and Marketing
8.4.1 Magnetic Coupled Mixers Sales Channels
8.4.2 Magnetic Coupled Mixers Distributors8.5 Magnetic Coupled Mixers Customers
9 Research Findings and Conclusion
10 Methodology and Data Source10.1 A Methodology
10.1.1 Research Process
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation10.2 B Data Source
10.2.1 Legal Disclaimer
-
The Global and United States Protein in Infant Formula Market has been segregated into various crucial divisions including applications, types, and regions. Each market segment is intensively studied in the report contemplating its market acceptance, worthiness, demand, and growth prospects. The segmentation analysis will help the client to customize their marketing approach to have a better command of each segment and to identify the most prospective customer base.
Report Objectives / Segmentation Covered :
By Companies / players:
By Regions:
By Type:
By Application:
Frequently asked questions(FAQ's):
Recognize the areas along the Global and United States Protein in Infant Formula Market's value chain where players are generating value. To get a complete picture, kindly read the entire report.
In recent years, the Global and United States Protein in Infant Formula Market has grown at an incredible rate. From 2024 to 2029, the market is expected to grow at a CAGR of yy%.
The value of the Global and United States Protein in Infant Formula Market is estimated to be USD XXX million.
The Global and United States Protein in Infant Formula study focuses on shifting market dynamics, geopolitical and regulatory regulations, and key players' strategies to carefully analyze demand at risk across multiple industry categories.
